Flex Work policy
Corporate Policy
Full time in office
About
Latigo Biotherapeutics is a privately-held, preclinical-stage biotechnology company focused on the development of novel therapeutics for cancer treatment. It is committed to leveraging its expertise in RNA biology and cancer biology to develop gene-editing technologies that target the undruggable genome and create proprietary oncology drug candidates. The company, established in 2020, is headquartered in Boston, Massachusetts.
This content was generated by A.I. Latigo Biotherapeutics employees can
to make any changes.